Lv1
40 积分 2025-10-20 加入
Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions
12天前
已完结
Probing Glycosyltransferase Activities with the Staudinger Ligation
13天前
已完结
Enzymatic glycan remodeling–metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering
13天前
已完结
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
16天前
已完结
Novel inhibitors of the PI3K family
16天前
已完结
Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
1个月前
已完结
Controlled Fab-arm exchange for the generation of stable bispecific IgG1
1个月前
已完结
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
1个月前
已完结
Discovery of the First Potent PI3K/mTOR Dual-Targeting PROTAC Degrader for Efficient Modulation of the PI3K/AKT/mTOR Pathway
1个月前
已完结
Enzymatic glycan remodeling–metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering
1个月前
已完结
皖公网安备34019202002308
